WebAurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2024, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy for the treatment of adult ... WebQ3 2024 JD.Com Inc Earnings Conference Call. ... JD.com Inc Fourth Quarter 2024 Results 121.9 KB. Q3. JD.com Inc Third Quarter 2024 Results 101.4 KB. Q2. JD.com Inc Second Quarter 2024 Results 237.7 KB. Q1. JD.com Inc First Quarter 2024 Results 245.3 KB. ... JD.Com Inc Fourth Quarter and Full Year 2014 Financial Results 411.7 KB. Q3.
NILE Stock: 9 Things to Know as Ault Global
WebMay 23, 2024 · Revenues from BitNile's cryptocurrency mining operations were $3.5 million for the three months ended March 31, 2024, compared to $0.1 million for three months … WebApr 27, 2024 · And GAAP diluted earnings per share was a dollar $1.68, up 54.1% year over year. Adjusted net income was $477 million for the quarter, up 12.2% year over year, and adjusted diluted earnings per ... bitwise or of two numbers in c++
BitNile Metaverse (BNMV) Earnings Dates & Reports
WebMay 23, 2024 · Revenues from BitNile’s cryptocurrency mining operations were $3.5 million for the three months ended March 31, 2024, compared to $0.1 million for three months … WebMar 31, 2024 · Email Alerts. BitNile Holdings Reports Q1 2024 Financial Results, Including Revenue of $33 Million, up 148% From the Prior First Fiscal Quarter. May 23, 2024 at … WebSep 30, 2024 · LAS VEGAS -- (BUSINESS WIRE)-- BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“ BitNile ” or the “ Company ”), reported its … date change automatically excel